Acellular pertussis vaccine as a booster dose for seventeen- to nineteen-month-old children immunized with either whole cell or acellular pertussis vaccine at two, four and six months of age.

@article{Halperin1995AcellularPV,
  title={Acellular pertussis vaccine as a booster dose for seventeen- to nineteen-month-old children immunized with either whole cell or acellular pertussis vaccine at two, four and six months of age.},
  author={Scott Alan Halperin and Elaine L. Mills and Luis Muniz Barreto and Carolyn P. Pim and Brian Eastwood},
  journal={The Pediatric infectious disease journal},
  year={1995},
  volume={14 9},
  pages={
          792-7
        }
}
The safety and immunogenicity of two formulations of an acellular pertussis vaccine as a booster at 17 to 19 months of age were assessed in children immunized at 2, 4 and 6 months of age with acellular or whole cell pertussis vaccine. In Study I 86 children primed with a five-component acellular vaccine combined with diphtheria and tetanus toxoids or with a whole cell pertussis-diphtheria-tetanus vaccine were boosted with the same vaccine. Local reactions (64% vs. 93%; relative risk, 0.7; 95… CONTINUE READING
BETA

Similar Papers

Citations

Publications citing this paper.
SHOWING 1-10 OF 11 CITATIONS

Adverse events Diphtheria toxoid vaccines

  • 2016
VIEW 1 EXCERPT
CITES BACKGROUND
HIGHLY INFLUENCED

Diphtheria and Tetanus Toxoids and Acellular Pertussis Vaccine Adsorbed DAPTACEL

Diphtheria DAPTACEL TM, Tetanus Toxoids
  • 2001
VIEW 1 EXCERPT
CITES BACKGROUND